Executive sessions were scheduled but no action was taken on SB 5298 – “Regarding labeling of marijuana products.”
- See details on SB 5298's Senate policy committee public hearing and executive session, and a Senate floor activity and amendment update. Engrossed Substitute SB 5298 (ESSB 5298) was passed by the full Senate on March 11th with two amendments. In the House, the Commerce and Gaming Committee hosted a policy committee public hearing prior to the executive session scheduled for Tuesday March 26th.
- Kyle Raymond, Committee Research Analyst, briefed the committee on a proposed amendment from Vick, 5298-S.E AMH COG RAYM 029, which “Exempts drug and pharmaceutical products approved by the United States Food and Drug Administration from the marijuana product labeling requirements of this section.” (audio – 1m, video)
- Chair Stanford informed members that the text of an amendment from him on the legislation would be emailed for their consideration (audio – 1m, video).
- Stanford said the bill “will be something we will come back to at our next meeting.” At the time of publication, ESSB 5298 was scheduled for executive session on April 2nd at 3:30pm (audio – 1m, video).